• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Adare Pharma Solutions

    Reed-Lane

    Emergent BioSolutions

    Flow Sciences

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Flow Sciences

    Aphena Pharma Solutions

    Alcami

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

    Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it.

    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    Related CONTENT
    • Almac Sciences Secures Support from Invest NI
    • iosBio Inks Exclusive Vax Platform Pact for COVID-19
    • Parexel Appoints Chief Patient Officer
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • Life Sciences Strive for Greater Agility
    Ben Locwin, Healthcare Science Advisors10.04.19
    Ever since there have been products, there have been counterfeit products distracting the consumer from the originator. There is a small philosophical difference between an originator product and a counterfeit—and that difference mostly centers around the idea of intellectual property (IP). IP attorneys spend long days justifying the differences, or lack thereof, between an originator and a copy. Trillions of dollars are made on knock-off products, and while some are of decent quality, others endeavor to convince consumers that they’re equivalent to the original product and (woefully) are not by a long shot. Oftentimes this discrepancy will manifest in a defective product and consumer frustration, but in the pharmaceutical market, counterfeits can lead to serious adverse events (SAEs) and even death.

    In pharmaceuticals, counterfeiting not only impacts IP of the originator molecule, but it undermines the safety of the public. Because unlike toys or gadgets, drug therapies go through a substantial demonstration of efficacy in clinical trials, so to intentionally develop inert, or hazardous, copies undermines the intent of the final product. This is where the ethical problems enter in the pharmaceutical counterfeiting market. Make no mistake: There is a tremendous incentive to counterfeit pharmaceutical products, as it is currently a scheme worth over $75 billion annually.1

    Techniques for anti-counterfeiting
    Branded labels and logos exist to signal to consumers that what they have is the original product. Of course, the counterfeitors then need to duplicate each of these product-specific idiosyncracies.

    There are many examples of anti-counterfeiting technology in pharmaceuticals that have been foiled: Manufacturer brand debossing on tablets can be copied; packages duplicated; tablet and capsule morphologies replicated; and containers cloned, or sourced from the same closure vendors. Those individuals most likely to be fooled by counterfeiting are first-time users of a drug therapy, because they have no mental baseline as a comparator. There are also a lot of first-time users of drug products. Think of the number of patients multiplied by the permutations of the number of marketed drug products.

    It was only a couple decades ago that holograms on stickers and logos were the 21st century approach to anti-counterfeiting. These are now easily duplicated by counterfeitors. Drug forms that come in novel delivery devices such as auto-injector pens, transdermal patches, etc., offer some inherent resistance to counterfeiting. But first-time users wouldn’t know what to expect.

    Now drugs that offer cutting-edge patient data tracking will provide some anti-counterfeiting comfort for the time being, until patients begin to refuse drug treatments that track compliance. Serialization allows for tracking and tracing to a certain degree across the supply chain and ensures greater chain of custody for the manufacturer, and as more pharmacies become a part of the serialization effort, the system gets more robust. But it does not demonstrate to patients that their prescription hasn’t been counterfeited.

    Special consideration for regulators
    This is a serious problem for the pharmaceutical industry, as it is for the technology sector, art, music, textiles, and virtually every other extant industry. Counterfeitors in the pharmaceutical sector, however, risk patients’ lives. There is a deep latent risk as well, and that comes in the form of post-marketing surveillance for safety reports. Knowing which reported adverse events (AEs) for a particular drug are from actual marketed drug or a counterfeit replacement is virtually impossible. Therefore knowing which post-marketing safety signals are false positives, which is already a difficult task, becomes more difficult when patients report adverse events and may have been taking a counterfeited prescription. It is therefore incumbent upon us as ambassadors for this industry to continue to seek methods to make counterfeiting more and more difficult. All patients who take a prescription and expect a certain beneficial effect, and at the same time a particular margin of safety, deserve the best products we can produce. CP

    References and Further Reading
    1. Moran, B. “Cracking Down on Counterfeit Drugs.” http://www.pbs.org/wgbh/nova/next/body/uncovering-counterfeit-medicines/
    2. Davison, M. (2011). Pharmaceutical anti-counterfeiting: Combating the real danger from fake drugs. Hoboken, NJ: John Wiley & Sons, Inc.

    Ben Locwin

    Dr. Ben Locwin, PhD, MBA, MS is president of Healthcare Science Advisors and an author of a wide variety of scientific articles for books and magazines, as well as an acclaimed speaker. He can be reached at ben.locwin@healthcarescienceadvisors.com.
    Related Searches
    • tablets
    • marketing
    • it
    • auto-injector
    Suggested For You
    Almac Sciences Secures Support from Invest NI Almac Sciences Secures Support from Invest NI
    iosBio Inks Exclusive Vax Platform Pact for COVID-19 iosBio Inks Exclusive Vax Platform Pact for COVID-19
    Parexel Appoints Chief Patient Officer Parexel Appoints Chief Patient Officer
    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021 The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Life Sciences Strive for Greater Agility Life Sciences Strive for Greater Agility
    ACG Appoints New CEO ACG Appoints New CEO
    Pre-filled Syringes & Injectable Drug Trends Pre-filled Syringes & Injectable Drug Trends
    August Bioservices Expands Operations in Nashville August Bioservices Expands Operations in Nashville
    Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study
    A Potential “Marriage” A Potential “Marriage”
    Injectables Firms Expand Capacity Injectables Firms Expand Capacity
    Inspecting the Unexpected Inspecting the Unexpected
    Opportunities in Synthetic Biology Opportunities in Synthetic Biology
    The Pandemic & The Pharma Industry: 3 Things to Know The Pandemic & The Pharma Industry: 3 Things to Know
    Pii Appoints Business Development Director Pii Appoints Business Development Director

    Related Columns

    • Clinical Trials
      Synthetic Control Arms

      Synthetic Control Arms

      In clinical trials, they don’t always capture the most important dimensions
      Ben Locwin 03.06.19

    • Clinical Trials | Process Development

      China Vaults to the Top of U.S. Biomanufacturers’ Off-Shoring Prospects

      A look at top destinations for future offshoring
      Eric S. Langer, BioPlan Associates 06.02.16

    • Clinical Trials

      Are More CRO Transactions Near?

      When will we see additional transactions involving the largest CROs?
      Chad Moore, Leerink Partners LLC 06.02.16


    • Biosimilars | Clinical Trials | Drug Discovery | Process Development

      Like the Temperature, It Feels Like Deal Activity is Heating Up

      A summary of 2016 transactions so far
      Chad Moore, Leerink Partners LLC 05.05.16

    • Analytical Services | Clinical Trials | Laboratory Testing | Supply Chain

      Analytical Instruments are On-Board with Outsourcing

      Newer process instruments are finally being designed with mobility in mind
      Emil W. Ciurczak, DoraMaxx Consulting 01.28.16

    • Biosimilars | Clinical Trials

      Outsourced Pharma Services: 2015 Review & 2016 Outlook

      ...
      Chad Moore, Leerink Partners 01.28.16


    • APIs | Biosimilars | Clinical Trials | Process Development | Vials

      2015 in Review: 6 Key Trends Affecting CMOs

      A look at major CMO trends ranging from budgets to growth opportunities
      Eric S. Langer, BioPlan Associates 11.17.15

    • Clinical Trials | Drug Development

      Recap of Notable Recent CRO Transactions

      Conditions are expected to remain favorable for M&A and capital markets activity in the pharmaceutical service and IT sector
      Chad Moore 10.07.15

    • Clinical Trials | Process Development

      Globalization Hits Biopharma Contract Manufacturing

      CMOs no longer need to be local, and some countries are set to benefit
      Eric S. Langer, BioPlan Associates 10.07.15


    • Clinical Trials

      Clinical Trial Participants: Why So Elusive?

      Looking at how some companies are improving clinical trial efficiency and speed to solve the clinical trial participant conundrum
      Chad Moore, Robert W. Baird & Co. Inc. 09.11.15

    • Clinical Trials | Drug Development

      Medical Affairs: The Next Wave of Outsourcing?

      Outsourcing of medical affairs is on the rise, creating opportunities for third-party providers
      Chad Moore, Robert W. Baird & Co. Inc. 07.14.15

    • Analytical Services | APIs | Bioanalytical Services | Biosimilars | Chemistry | Clinical Trials | Excipients | GMPs/GCPs | Laboratory Testing | Microbiology | QA/QC | R&D | Regulatory Affairs | Supply Chain | Toxicology | Validation

      Inventas vitam iuvat excoluisse per artes (Let us improve life through science and art)

      But Qui bono? (Who benefits?)
      Emil W. Ciurczak, DoraMaxx Consulting 07.14.15


    • Clinical Trials

      Why Do Americans Pay More for Cancer Treatments?

      The ever-increasing cost of cancer treatments globally is a constant cause for discussion and price negotiation between Pharma companies and health care providers
      Adele Graham-King, Contributing Editor 05.06.15

    • Clinical Trials | Drug Development

      M&A Activity Heats Up

      Last year was hot, but 2015 looks to be hotter.
      Chad Moore, Robert W. Baird & Co. Inc. 01.29.15

    • Capsules | Cleaning Validation | Clinical Trials | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development | R&D | Serialization | Supply Chain | Validation

      Sometimes, Even a Good Workman Can Blame His Tools

      A new generation of equipment will help generate products with less cost and effort, while being made more efficiently.
      Emil W. Ciurczak, DoraMaxx Consulting 01.29.15

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • A New Era Of Vaccine And Biologic Drug Development
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login